Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017950HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059146HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059148HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059150HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059149HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10059147HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TVIS10060220HBVENSG00000229314.6protein_codingORM1NoNo5004P02763
TCGA Plot Options
Drug Information
GeneORM1
DrugBank IDDB00276
Drug NameAmsacrine
Target IDBE0000925
UniProt IDP02763
Regulation Type
PubMed IDs10803926
CitationsFinlay GJ, Baguley BC: Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Cancer Chemother Pharmacol. 2000;45(5):417-22.
GroupsApproved; Investigational
Direct ClassificationAcridines
SMILESCOC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Pathways
PharmGKBPA10309
ChEMBLCHEMBL43